Ribosome (RPL; 40S; 60S) Inhibitors

Ribosomes, comprising the 40S (small subunit) and 60S (large subunit) in eukaryotes, are essential for cellular protein synthesis, often referred to as translation. They function by decoding messenger RNA (mRNA) sequences and catalyzing the synthesis of polypeptides, the building blocks of proteins. The 40S subunit is responsible for the binding and reading of mRNA, while the 60S subunit facilitates the formation of peptide bonds between amino acids. This process is highly regulated and involves various stages: initiation, elongation, termination, and ribosome recycling. Ribosomes are also involved in controlling the rate of protein synthesis, which is crucial for maintaining cellular homeostasis and responding to environmental cues. Malfunction or alterations in ribosomal function can lead to various cellular issues.

Targeting eukaryotic ribosomal function for disruption or inhibition is a strategy used in research settings, often for its implications in studying fundamental biological processes. Inhibitors of ribosomal function can affect different stages of protein synthesis, leading to a decrease or complete halt in protein production. These inhibitors, ranging from specific compounds to cytotoxic agents, selectively bind to either the 40S or 60S subunit, interfering with their normal functions. Such interventions can be useful for studying gene expression, investigating the role of specific proteins, or controlling diseases like cancer, where rapid cell division is driven by increased protein synthesis.